Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Brenntag core earnings beat estimates in Q1, confirms guidance

Published 10/05/2023, 06:47
Updated 10/05/2023, 11:18
© Reuters.

By Matteo Allievi and Jagoda Darlak

(Reuters) -German chemicals distributor Brenntag on Wednesday beat first-quarter core profit expectations, helped mainly by growth in its Essentials division, which makes chemicals for industries ranging from food to oil and gas.

The company reported operating earnings before interest, taxation, depreciation and amortisation (EBITDA) of 420.4 million euros ($462.8 million) for the quarter, above analysts' estimates of 406.6 million euros in a poll by Vara Research.

Energy prices are decreasing as inflation has passed its peak in Germany, and global supply chain problems have eased as economies, including China, loosen COVID-19 curbs, with chemical distributors benefiting from a pick up in volumes of raw materials.

However, core earnings were 9% below the same period from a year ago amid a still challenging macro-economic environment.

"Inflation-driven increases in costs and falling demand also made it difficult to repeat the strong prior-year results," the company said in a statement.

Europe, the Middle East and Africa (EMEA) and the Americas were the strongest markets, whereas the performance in the Asia Pacific (APAC) segment was weaker, as it was not yet seeing the impact from a recovery in China, the Essen-based company said.

Brenntag confirmed its previous guidance for 2023, still seeing an operating EBITDA range between 1.6 billion euros and 1.8 billion euros.

"We observed a gradual monthly improvement in demand, with early indications for a positive Q2 volume development continuing," Chief Executive Officer Christian Kohlpaintner said.

Analysts at Baader said the guidance range for 2023 might be conservative, expecting Brenntag to achieve at least the upper end of its range.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Only Brenntag's Essentials division managed to grow its profits in the first quarter, while the Specialties business, which provides services to industries such as nutrition, pharmaceuticals and household products, was affected by high costs and falling demand.

The disparity in the performance of the two divisions highlights the reason why investors have been calling on Brenntag to spin off the Specialties unit, arguing it would boost the share price.

Shares were down 1% at 0919 GMT.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.